TS
BIIB icon

Triglav Skladi’s Biogen BIIB Stock Holding History

Triglav Skladi’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
12,976
+548
+4% +$105K 0.15% 88
2026
Q1 		$2.28M Buy
12,428
+298
+2% +$54.9K 0.16% 80
2025
Q4 		$2.13M Sell
12,130
-6,000
-33% -$980K 0.13% 92
2025
Q3 		$2.54M Buy
18,130
+103
+0.6% +$13.9K 0.17% 70
2025
Q2 		$2.26M Hold
18,027
– – 0.16% 71
2025
Q1 		$2.47M Hold
18,027
– – 0.21% 69
2024
Q4 		$2.76M Buy
+18,027
New +$3.04M 0.22% 60

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Triglav Skladi's BIIB Position: Q2 2026 in Review

Triglav Skladi increased its Biogen (BIIB) stake by 4.4% in Q2 2026, buying an estimated $105K and bringing the position to 12,976 shares worth $2.8M. The position accounts for 0.15% of the portfolio, ranked #88.

Triglav Skladi first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Triglav Skladi held 12,976 shares of Biogen worth $2.8M as of Q2 2026.
  • Triglav Skladi bought 548 Biogen shares in Q2 2026, an estimated $105K.
  • Biogen made up 0.15% of Triglav Skladi's portfolio in Q2 2026, its #88 holding.
  • Triglav Skladi first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.